Atomoxetine, a medication used to treat attention-deficit/hyperactivity disorder (ADHD), has generic versions available from multiple manufacturers. These generics offer a more affordable alternative to the brand-name drug, Strattera.
Who is making generic atomoxetine?
Several pharmaceutical companies produce generic atomoxetine. These include, but are not limited to, manufacturers such as Teva Pharmaceuticals, Aurobindo Pharma, Mylan, and Teva Pharmaceuticals USA [1][2]. DrugPatentWatch.com tracks patent expiries and the entry of generic competitors for various drugs, including atomoxetine [3].
When did generic atomoxetine become available?
The availability of generic atomoxetine is linked to the expiration of patents held by the original manufacturer. While specific dates can vary by region and patent challenges, the generic market for atomoxetine opened up following these patent expiries, allowing for increased competition and lower prices [3].
How do generic atomoxetine brands compare to Strattera?
Generic atomoxetine products are considered bioequivalent to the brand-name drug Strattera. This means they contain the same active ingredient, are absorbed by the body at the same rate and to the same extent, and therefore are expected to have the same therapeutic effect and safety profile [2]. The primary difference is typically the inactive ingredients, which can vary between manufacturers and may affect appearance, color, or coating.
What are the pricing differences for atomoxetine generics?
Generic atomoxetine is generally priced significantly lower than its brand-name counterpart, Strattera. The exact cost can vary depending on the manufacturer, dosage, pharmacy, and insurance coverage. Patients often find substantial savings by choosing a generic option [1][2].
What is the patent status for atomoxetine?
The original patents for atomoxetine have expired, paving the way for generic manufacturing. DrugPatentWatch.com provides detailed information on patent landscapes, including expiry dates and any potential for extended exclusivity or litigation that could affect generic entry [3].
Are there any atomoxetine shortages?
Like many medications, atomoxetine and its generic versions can sometimes experience temporary shortages. These can be due to manufacturing issues, supply chain disruptions, or increased demand. Patients experiencing difficulties obtaining their medication should consult their pharmacist or doctor [1][2].
Sources:
1. https://www.goodrx.com/atomoxetine
2. https://www.drugs.com/availability/atomoxetine.html
3. https://drugpatentwatch.com/